Nautilus Biotechnology, Inc. (NAUT) Net income 2020–2025
Nautilus Biotechnology, Inc. (NAUT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$59.0MFY2025 · since FY2020: -$15.6M → -$59.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$59.0M | +16.6% |
| FY2024 | -$70.8M | -11.2% |
| FY2023 | -$63.7M | -9.9% |
| FY2022 | -$57.9M | -15.1% |
| FY2021 | -$50.3M | -222.1% |
| FY2020 | -$15.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice